Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹40 Cr₹45 Cr₹41 Cr₹15 Cr₹9.56 Cr

What is the latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS ?

The latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS is ₹40 Cr based on Mar2025 Standalone results.
Year Sundry Debtors
Mar2025₹40 Cr
Mar2024₹45 Cr
Mar2023₹41 Cr
Mar2022₹15 Cr
Mar2021₹9.56 Cr

How is Sundry Debtors of BAFNA PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2025 ₹40 Cr
-11.50
Mar2024 ₹45 Cr
10.32
Mar2023 ₹41 Cr
178.41
Mar2022 ₹15 Cr
54.60
Mar2021 ₹9.56 Cr -

Compare Sundry Debtors of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹272.6 Cr -4.2% -1.5% 43.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,613.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹167,105.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,926.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹109,088.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,120.0 Cr -1.3% 0.9% -8.9% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-4.2%

-1.5%

43.2%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses